Main Subject - Business

One of the things that medical billing companies don't like about DME software companies is how they nickel and dime them for just about every

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

thing that comes with the software. One of the biggest areas where this is a major source of pain is with user licenses.

When you purchase y

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

our DME software, most software companies sell the software in two different versions. One version is standalone, to be used on a single PC a

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

d the other version is to be used on the network. There is more different between these two versions than just the fact that one version runs

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

standalone and the other runs on the network. The biggest difference is the user licenses that come with each version.

Usually, by default,

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

with the standalone version, you will get a user license for only one user. If you want to install the standalone system on multiple PCs, as

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

uming you don't need network support, then you have to purchase additional licenses. These licenses can cost as much as a couple hundred doll

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ars or more, depending on how complex the software is and the original cost.

The network version gets a little more complicated. Because the

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

software runs on a network, usually the number of people who can access that network is controlled by the network itself and not by the softw

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

re. But software companies have this covered very well. What they do is make it so that when the software is installed, it places data on th

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e network that indicates how many people can connect to the software at one time. Once the maximum number of users is reached, no other users

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

will be allowed to connect.

Most software packages come with anywhere from five to twenty licenses to begin with. If a medical billing comp

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ny wants additional licenses, then they have to pay for them. When they do this, what the software company does is go into the system and cha

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

nge the area containing the data that stores the number of licenses in the system. This is usually an area that can only be access by a speci

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

al login.

The licenses for a network system are usually sold in packages. In other words, let's say you get your stock system and it comes w

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

th 20 user licenses. In your company, you happen to have 61 users. The software company only sells upgrades in increments of 20 users for ea

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ch upgrade at $500 for each 20 users. If you buy two 20 user upgrades, that comes out to $1000. But look what happens. You only have 60 use

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

r licenses. You still have 1 person who can't access the system. The last thing you want to do is spend $500 for 20 more user licenses when

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ou only need one more. Unfortunately, this is your only option if you want your final user to access the network.

User licenses for medical

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

billing are big business. Almost as big a business as the medical billing industry itself. And you wonder why your medical costs are so high

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/1955/mainsubjects-Medical-Billing--User-Licenses.html">Medical Billing - User Licenses</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/1955/mainsubjects-Medical-Billing--User-Licenses.html]Medical Billing - User Licenses[/url]

Laser technology has tremendously impacted the tube-cutting industry, making tube-cutting fast, easy and exciting. This article explores some of its boons.

Several entities determine the outcome of your annual property tax bill. While the names of these entities vary from state to state and from time to time, the names used in Florida generally exemplify the roles of the various entities in determining your property tax bill.

If you're thinking of getting into medical billing and sending claims in for oxygen, you better bone up on your GX records. In this installment, we cover the GX0 record, fields 14 through 19.

Tags

Links

Main Subject - Medical Billing - User Licenses

Related Articles: